BethLabQueen said:A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin…
Careful with treating an unchanged LDL-C as a failure. If ApoB and triglycerides both fell, the particle picture improved regardless of what the calculated LDL says.
Adding the numbers, since they settle part of this. Post reference ranges alongside numbers when you share them. Units differ by country — glucose and lipids especially — and half the confusion in these threads is unit mismatch rather than disagreement.
TrialTracker_MD said:Careful with treating an unchanged LDL-C as a failure.
Adding the part of the answer the thread has not reached. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
Happy to go further on any of that.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOne thing that is still open after JessicaM_2024’s answer:
How often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning?
Reporting back.
Took the whole panel in rather than the one flagged line, and the conversation lasted two minutes instead of generating three more tests.